Anda di halaman 1dari 2

[Lecture No.

1]: Overview of GPP and current regional status


1. Among GPP core functions, which one is the most difficult to implement in
your country? And why? And what would be potential strategies to
overcome?
2. What would be potential/feasible GPP model(s) which can be considered to
implement in your country?
3. What are the facilitators for implementing GPP in your country?

[Lecture No. 2]: Ambulatory patient care
1. How to prevent medication error in your hospital or country ? ( for
ambulatory care)
Please state by four parts as bellow
Prescription
Dispensing
Training program
Other
2. Is there any procedure or device to make sure pharmacist acknowledge
patient appropriately?
Note :
Please complete above question by word and power point file
Power point :
Please provide text and photo about your hospital condition in your slides to
help us realize your condition and questions.

[Lecture No. 3]: Inpatient care
1. Please describe the inpatient pharmaceutical services, such as dispensing
medications, screening medication orders for appropriateness, or identifying
and reporting adverse drug reactions and medication errors, etc., in your
hospital (country).
2. In order to comply with the WHO GPP guidelines, what will be the next
pharmaceutical service (including quality improvement programs) that you
want to implement in your institution? How are you going to evaluate the
performance of this new service?

[Lecture No. 4]: Non-cytotoxic and cytotoxic sterile preparation
<Not Yet Received from the Lecturer>

[Lecture No. 5]: Drug Procurement and inventory management
1. Are you satisfied the inventory control system in your hospital? After this
lecture, what is your plan to improve it?
2. Do you think barcode implement is a good way for medication safety?
Which step will you implement in the medication use process?

[Lecture No. 6]: Clinical pharmacy services and patient education
1. Please describe the manpower and highlight the current models of clinical
pharmacy service in your hospital or in your country.
2. What are the current challenges for providing/developing clinical pharmacy
services in your country/hospital settings?
3. Please prioritize the types of clinical pharmacy services which can be
implemented in your country/hospital settings.

[Lecture No. 7]: Drug information and nationwide reporting systems
1. (1) What information service you have not provided to patients but you
want to start now? Share and compare your current service with team
members.
(2) Please design a protocol of information service for your pharmacy.
(20 mins discussion, 5 mins report)
2. Please compare the current reporting system in your practice with those
in your team members about:
How do you report the adverse drug reactions and/or medication errors?
How do you feedback to patients and healthcare professionals about the
findings from reporting systems?
Is there any difference? What have you learned from your members or from
this workshop and what will you like to apply to your practice?
(20 mins discussion, 5 mins report)

[Lecture No. 8]: Continuing professional development
Before coming to the meeting, the representative of each country should
provide brief introduction focusing on following 3 aspects in fulfilling the CPD
of WHO GPP guideline and share the experience in speaking while attending
this lecture personally.
@ CPD program on new pharmacy graduates
^ The duration of program
^ Definition of new graduate
^ Qualification of the trainer
^ The source of financial support
^ Other information
@ Pharmacist advancement program
^ The number of advancement levels
^ The elements of requirement in the advancement program
^ The relationship of the advancement levels and salary
@ Required continuing education credits for renewing pharmacist licensure
^ Number of credit hours in number of years
^ Any required credit hours on specific subjects among the total required
credit hours
^ The requirement for a CE approval organization